Oxford Financial Group, Ltd. Llc
Source: SEC Form 13F · as of Mar 2026Oxford Financial Group, Ltd. Llc holds 17 biotech & pharma companies tracked by BioSniper, totaling $127.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$127.2M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 129,619 | $119.2M |
| JNJJOHNSON & JOHNSON | 9,214 | $2.3M |
| ABBVAbbVie Inc. | 4,717 | $1.0M |
| AMGNAMGEN INC | 1,760 | $619K |
| PMPhilip Morris International Inc | 3,231 | $534K |
| MRKMerck & Co., Inc. | 4,165 | $501K |
| ABTABBOTT LABORATORIES | 4,823 | $495K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 900 | $402K |
| GMOptec International, Inc. | 5,040 | $375K |
| NVONovo Nordisk A/S | 10,168 | $374K |
| AZNASTRAZENECA PLC | 1,522 | $300K |
| BMYBRISTOL MYERS SQUIBB CO | 4,808 | $292K |
| CAHCardinal Health Inc. | 1,344 | $284K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 942 | $255K |
| GEHCGE HealthCare Technologies Inc. | 2,882 | $205K |
| IVVDInvivyd, Inc. | 23,094 | $30K |
| LCTXLineage Cell Therapeutics, Inc. | 12,630 | $20K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.